Showing results (381-390 of 447) with videos related to
Sort By:
Pageof 45
Journal of the American College of Cardiology|June 26, 2012
Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantationLutz Buellesfeld, Stefan Stortecky, Dik Heg, et al.Journal of the American College of Cardiology|October 2, 2007
A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery diseaseAlbert Schömig, Alban Dibra, Stephan Windecker, et al.Lancet (London, England)|September 2, 2018
Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trialThomas Pilgrim, Raffaele Piccolo, Dik Heg, et al.Cells|April 3, 2021
Asymmetrical Forces Dictate the Distribution and Morphology of Platelets in Blood ClotsTatiana A Kovalenko, Marie-Noelle Giraud, Anita Eckly, et al.Swiss Medical Weekly|May 17, 2021
Coronary and structural heart interventions in Switzerland 2019Max Wagener, Raphael Twerenbold, Stéphane Cook, et al.Journal of the American College of Cardiology|September 4, 2019
Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS)Konstantinos C Koskinas, Stephan Windecker, Giovanni Pedrazzini, et al.Lancet (London, England)|September 6, 2014
Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trialThomas Pilgrim, Dik Heg, Marco Roffi, et al.Heart (British Cardiac Society)|February 6, 2016
Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary interventionMatthijs A Velders, Jérémie Abtan, Dominick J Angiolillo, et al.The New England Journal of Medicine|August 18, 2005
Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularizationStephan Windecker, Andrea Remondino, Franz R Eberli, et al.Circulation. Cardiovascular Interventions|July 10, 2015
Effect of Pulmonary Hypertension Hemodynamic Presentation on Clinical Outcomes in Patients With Severe Symptomatic Aortic Valve Stenosis Undergoing Transcatheter Aortic Valve Implantation: Insights From the New Proposed Pulmonary Hypertension ClassificationCrochan J O'Sullivan, Peter Wenaweser, Osman Ceylan, et al.Pageof 45